Perseus Proteomics Inc. (TYO:4882)

Perseus Proteomics Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,668	1,541	2,444	3,214	1,069
Cash & Short-Term Investments	1,668	1,541	2,444	3,214	1,069
Cash Growth	8.24%	-36.95%	-23.96%	200.65%	121.78%
Accounts Receivable	22.21	13	9	10	8
Other Receivables	50.3	70	41	35	21
Receivables	72.51	83	50	45	29
Inventory	5.31	4	3	3	1
Prepaid Expenses	11.47	5	7	4	4
Other Current Assets	18.75	17	10	24	5
Total Current Assets	1,776	1,650	2,514	3,290	1,108
Long-Term Investments	42.86	42	51	9	9
Other Long-Term Assets	0	1	1	1	1
Total Assets	1,819	1,693	2,566	3,300	1,118
Accounts Payable	61.01	1	1	-	1
Accrued Expenses	41.61	57	28	11	8
Current Income Taxes Payable	18.27	66	66	134	24
Other Current Liabilities	3.97	4	16	3	1
Total Current Liabilities	124.87	128	111	148	34
Other Long-Term Liabilities	261.57	167	59	-	1
Total Liabilities	386.43	295	170	148	35
Common Stock	2,438	1,971	1,939	1,939	604
Additional Paid-In Capital	2,724	2,256	2,225	2,225	889
Retained Earnings	-3,809	-2,903	-1,799	-1,012	-413
Treasury Stock	-0.02	-	-	-	-
Comprehensive Income & Other	79.22	74	31	-	3
Shareholders' Equity	1,432	1,398	2,396	3,152	1,083
Total Liabilities & Equity	1,819	1,693	2,566	3,300	1,118
Net Cash (Debt)	1,668	1,541	2,444	3,214	1,069
Net Cash Growth	8.24%	-36.95%	-23.96%	200.65%	121.78%
Net Cash Per Share	116.89	130.72	207.83	292.27	152.72
Filing Date Shares Outstanding	14.75	11.85	11.76	11.75	8.36
Total Common Shares Outstanding	14.75	11.85	11.76	11.75	8.36
Working Capital	1,651	1,522	2,403	3,142	1,074
Book Value Per Share	97.12	118.00	203.75	268.36	129.53
Tangible Book Value	1,432	1,398	2,396	3,152	1,083
Tangible Book Value Per Share	97.12	118.00	203.75	268.36	129.53
Buildings	1.28	-	-	-	-
Machinery	89.4	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.